What is NBM?
The National Biopharma Mission (NBM) is an industry-Academia Collaborative Mission for accelerating biopharmaceutical development in the country.
Innovate in India
Under this Mission the Government has launched Innovate in India (i3) programme to create an enabling ecosystem to promote entrepreneurship and indigenous manufacturing in the sector.
Implementation
The mission will be implemented by Biotechnology Industry Research Assistance Council (BIRAC). 50% funding from World Bank loan.
Details of the Mission
The program is promoting entrepreneurship by supporting small and medium enterprises for indigenous product development (Novel Cell lines, indigenously developed Biologics, devices and Raw materials for Biologics manufacturing) and through establishment of shared facilities and Technology Transfer Offices.
This scientifically driven enterprise aims at developing an ecosystem for affordable product development and is focused on the following 4 verticals:
- Development of product leads for Vaccines , Biosimilars and Medical Devices that are relevant to the public health need by focussing on managed partnerships.
- Upgradation of shared infrastructure facilities and establishing them as centres of product discovery/discovery validations and manufacturing.
- Develop human capital by providing specific trainings to address the critical skills gap among the nascent biotech companies across the product development value chain in areas such as Product development, intellectual property registration, technology transfer and regulatory standards.
- Technology Transfer Offices: To help enhance industry academia inter-linkages and provide increased opportunities for academia, innovators and entrepreneurs to translate knowledge into products and technologies
